Report #2850216

Received Jul 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 65 yrs
State: IL
Recovered: Unknown
Vaccinated: Jul 14, 2025
Onset: Jul 14, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	3	UNK	LA

Symptoms (1)

Extra dose administered

Symptom narrative

Extra dose administered; This non-serious case was reported by a consumer via call center representative and described the occurrence of extra dose administered in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Received 1st dose of Shingrix vaccine in 2019) and Shingrix (Received 2nd dose of Shingrix vaccine in 2019). On 14-JUL-2025, the patient received the 3rd dose of Shingrix (left deltoid). On 14-JUL-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: Extra dose administered). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 14-JUL-2025 The patient had already received both doses of the Shingrix vaccine in 2019 and mistakenly got the vaccine again today which led to extra dose administered.